NanoBioTechnology Market

Nano biotechnology combines nano technology and biotechnology including special physicochemical and biological properties of nanostructures and their applications in numerous fieldslike medicine and agriculture. Nanobiotechnology is one of the most promising technologies in the 21st century. It plays a major role in developing and implementing many useful tools in the study of life. Its application in medicine involves disease diagnosis, target-specific drug delivery and molecular imaging. It also has application in agriculture and food. The factors such as increasing demand for the innovative drug in the pharmaceutical industry, rise in the application of nano biotechnology electronics, energy production and biomaterials and increased research & development investment are the key drivers of the global nano biotechnology market.

NanoBioTechnology Market contains market size and forecasts of NanoBioTechnology (NBT) in Global, including the following market information:

• Global NanoBioTechnology (NBT) Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global top five companies in 2021 (%)

The global NanoBioTechnology (NBT) market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

0-10 nm Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of NanoBioTechnology (NBT) include Ablynx (Belgium), Nami Therapeutics (US), Celgene Corporation (US), Nanophase Technologies Corporation (US), Sigma-Aldrich (US), SkyePharma Pharmaceuticals (France), Nano Bridging Molecules SA (Switzerland), XanTecbioanalytics GmbH (Germany) and Nanobiotix(France) and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the NanoBioTechnology (NBT) companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global NanoBioTechnology (NBT) Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global NanoBioTechnology (NBT) Market Segment Percentages, by Type, 2021 (%)

• 0-10 nm
• 10-100 nm

Global NanoBioTechnology (NBT) Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global NanoBioTechnology (NBT) Market Segment Percentages, by Application, 2021 (%)

• Pharmaceuticals
• Medical Research
• Food and Agriculture
• Others

Global NanoBioTechnology (NBT) Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global NanoBioTechnology (NBT) Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies NanoBioTechnology (NBT) revenues in global market, 2017-2022 (estimated), ($ millions)
• Key companies NanoBioTechnology (NBT) revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Ablynx (Belgium)
• Nami Therapeutics (US)
• Celgene Corporation (US)
• Nanophase Technologies Corporation (US)
• Sigma-Aldrich (US)
• SkyePharma Pharmaceuticals (France)
• Nano Bridging Molecules SA (Switzerland)
• XanTecbioanalytics GmbH (Germany)
• Nanobiotix(France)
• Dabur Pharma (India)